Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
- PMID: 32517540
- PMCID: PMC7286355
- DOI: 10.2217/pgs-2020-0059
Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?
Keywords: COVID-19; SARS-CoV-2; cancer; neoplasm; targeted therapy.
Comment on
-
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.Cancer Discov. 2020 Jun;10(6):783-791. doi: 10.1158/2159-8290.CD-20-0422. Epub 2020 Apr 28. Cancer Discov. 2020. PMID: 32345594 Free PMC article. Clinical Trial.
References
-
- Wang Z, Wang J, He J. Active and effective measures for the care of patients with cancer during the COVID-19 spread in China. JAMA Oncol. 6(5), 631–632 (2020). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous